Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid

Carcinogenesis. 1990 Jan;11(1):55-61. doi: 10.1093/carcin/11.1.55.

Abstract

In this report, we describe the ability of ellagic acid (EA), a phenolic compound present in a number of fruits and nuts, to inhibit N-nitrosobenzylmethylamine (NBMA) tumorigenesis in the rat esophagus. When administered in a semi-purified diet at concentrations of 0.4 and 4 g/kg, EA produced a significant (21-55%) decrease in the average number of NBMA-induced esophageal tumors after 20 and 27 weeks of the bioassay. EA exhibited inhibitory effects toward preneoplastic lesions as well as neoplastic lesions. Tumors were not observed in vehicle-control rats or in rats that received EA alone.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Benzopyrans / therapeutic use*
  • Dimethylnitrosamine / toxicity
  • Ellagic Acid / therapeutic use*
  • Esophageal Neoplasms / chemically induced
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / prevention & control*
  • Esophagus / drug effects
  • Esophagus / pathology*
  • Male
  • Rats
  • Rats, Inbred F344

Substances

  • Antineoplastic Agents
  • Benzopyrans
  • Ellagic Acid
  • nitrosobenzylmethylamine
  • Dimethylnitrosamine